home All News open_in_new Full Article

Edinburgh firm's new high street cataract treatment receives investment boost

Edinburgh Biosciences, the company behind a revolutionary new non-surgical treatment for cataracts has received a £2.3m loan investment from Contamac Ltd a company whose major shareholder is also a major shareholder in Edinburgh Biosciences.


today 8 h. ago attach_file Economics

attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics


ID: 1249460860
Add Watch Country

arrow_drop_down